Connection

Charles Bennett to Health Care Costs

This is a "connection" page, showing publications Charles Bennett has written about Health Care Costs.
Connection Strength

2.167
  1. The excessive cost of early stage bladder cancer care: are providers really to blame? Cancer. 2010 Aug 01; 116(15):3530-2.
    View in: PubMed
    Score: 0.280
  2. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Cancer. 2008 Sep 15; 113(6):1446-52.
    View in: PubMed
    Score: 0.246
  3. Cancer-associated neutropenic fever: clinical outcome and economic costs of emergency department care. Oncologist. 2007 Aug; 12(8):1019-26.
    View in: PubMed
    Score: 0.227
  4. Cost considerations in the management of cancer in the older patient. Oncology (Williston Park). 2007 Jun; 21(7):851-7; discussion 858, 860, 862 passim.
    View in: PubMed
    Score: 0.225
  5. Evaluating the total costs of cancer. The Northwestern University Costs of Cancer Program. Oncology (Williston Park). 2003 Jan; 17(1):109-14; discussion 119-21.
    View in: PubMed
    Score: 0.165
  6. Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project. J Clin Oncol. 2000 Aug; 18(15):2805-10.
    View in: PubMed
    Score: 0.140
  7. Comparing cost-effectiveness analyses for the clinical oncology setting: the example of the Gynecologic Oncology Group 111 trial. Cancer Invest. 2000; 18(3):261-8.
    View in: PubMed
    Score: 0.134
  8. Why Biologics and Biosimilars Remain So Expensive: Despite Two Wins for Biosimilars, the Supreme Court's Recent Rulings do not Solve Fundamental Barriers to Competition. Drugs. 2018 Nov; 78(17):1777-1781.
    View in: PubMed
    Score: 0.124
  9. Health care economics and bone marrow transplantation. Cancer Treat Res. 1997; 77:377-99.
    View in: PubMed
    Score: 0.109
  10. Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991. J Clin Oncol. 1995 Apr; 13(4):969-73.
    View in: PubMed
    Score: 0.097
  11. Medical care costs of intravenous drug users with AIDS in Brooklyn. J Acquir Immune Defic Syndr (1988). 1992; 5(1):1-6.
    View in: PubMed
    Score: 0.077
  12. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. Oncologist. 2007 Apr; 12(4):478-83.
    View in: PubMed
    Score: 0.056
  13. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol. 2004 Sep 01; 22(17):3524-30.
    View in: PubMed
    Score: 0.046
  14. The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol. 2004 May-Jun; 2(3):271-8.
    View in: PubMed
    Score: 0.045
  15. Does reimbursement affect physician decision making? Cancer Treat Res. 2000; 102:137-49.
    View in: PubMed
    Score: 0.034
  16. Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995. Bone Marrow Transplant. 1999 Sep; 24(6):679-84.
    View in: PubMed
    Score: 0.033
  17. Cost analysis of second-line therapies for platinum-refractory ovarian cancer: reimbursement dilemmas for Medicare patients. Cancer Invest. 1999; 17(8):559-65.
    View in: PubMed
    Score: 0.031
  18. Cancer insurance policies in Japan and the United States. West J Med. 1998 Jan; 168(1):17-22.
    View in: PubMed
    Score: 0.029
  19. Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers? Cancer. 1996 May 01; 77(9):1854-61.
    View in: PubMed
    Score: 0.026
  20. Performance measurement in prostate cancer care: beyond report cards. Urology. 1996 Mar; 47(3):356-65.
    View in: PubMed
    Score: 0.026
  21. Purchasing oncology services. Kerr L. White Institute/American Cancer Society Task Force on Purchasing Oncology Services. Cancer. 2000 Jun 15; 88(12):2876-86.
    View in: PubMed
    Score: 0.009
  22. Comparative study of the clinical efficacy of two dosing regimens of flutamide. Mol Urol. 2000; 4(3):259-63;discussion 265.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.